Latest & greatest articles for colorectal cancer

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on colorectal cancer or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on colorectal cancer and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for colorectal cancer

21. Prognosis Value of Low microRNA-34a Expression in Human Gastrointestinal Cancer: A Meta-Analysis Full Text available with Trip Pro

Prognosis Value of Low microRNA-34a Expression in Human Gastrointestinal Cancer: A Meta-Analysis Prognosis Value of Low microRNA-34a Expression in Human Gastrointestinal Cancer: A Meta-Analysis | Research Square Browse Tools & Services Your Cart See the published version of this article at . This is a preprint, a preliminary version of a manuscript that has not completed peer review at a journal. Research Square does not conduct peer review prior to posting preprints. The posting of a preprint (...) on this server should not be interpreted as an endorsement of its validity or suitability for dissemination as established information or for guiding clinical practice. Research article Prognosis Value of Low microRNA-34a Expression in Human Gastrointestinal Cancer: A Meta-Analysis Yan-Ling Chen, Xiao-Lin Liu, Ling Li Yan-Ling Chen First Affiliated Hospital of Soochow University ORCiD: https://orcid.org/0000-0002-3196-1053 Xiao-Lin Liu The First Affiliated Hospital of Soochow University Corresponding Author

2020 Research Square

22. Variation rs9929218 and Risk of the Colorectal Cancer and Adenomas: A Meta-analysis Full Text available with Trip Pro

Variation rs9929218 and Risk of the Colorectal Cancer and Adenomas: A Meta-analysis Variation rs9929218 and Risk of the Colorectal Cancer and Adenomas: A Meta-analysis | Research Square Browse Tools & Services Your Cart This preprint is under consideration at BMC Cancer . A preprint is a preliminary version of a manuscript that has not completed peer review at a journal. Research Square does not conduct peer review prior to posting preprints. The posting of a preprint on this server should (...) not be interpreted as an endorsement of its validity or suitability for dissemination as established information or for guiding clinical practice. Research article Variation rs9929218 and Risk of the Colorectal Cancer and Adenomas: A Meta-analysis Huiyan Wang, Dongying Gu, Miao Yu, Yanjun Hu, Zhe Chen, Xinying Huo, Tao Yu, Jinfei Chen, Yang Zheng Huiyan Wang Liaoning Cancer Institute and Hospital Dongying Gu Nanjing First Hospital Miao Yu Liaoning Cancer Institute and Hospital Yanjun Hu Liaoning Cancer Institute

2020 Research Square

23. Expert guidance on screening for colorectal and pancreatic cancer in BRCA1 and BRCA2 carriers

Expert guidance on screening for colorectal and pancreatic cancer in BRCA1 and BRCA2 carriers Expert guidance on screening for colorectal and pancreatic cancer in BRCA1 and BRCA2 carriers | American Gastroenterological Association Login here Gastro.org Gastro.org AGA Journals AGA Journals AGA’s peer-reviewed journals offer high-quality research on current advances in GI and hepatology. Access the latest research from Gastroenterology , Clinical Gastroenterology and Hepatology , Cellular (...) and Molecular Gastroenterology and Hepatology , and Techniques and Innovations in Gastrointestinal Endoscopy . AGA University AGA University AGA University is your home for in-person meetings, webinars and other educational tools designed to help you stay current with advances in the GI field and earn MOC/CME. AGA Research Foundation AGA Research Foundation The AGA Research Foundation funds young investigators who are committed to advancing gastroenterology. Through research, we can identify new treatment

2020 American Gastroenterological Association Institute

24. Efficacy and safety of traditional Chinese medicine decoction combined with chemotherapy in the treatment of advanced colorectal cancer A protocol of a systematic review and meta-analysis Full Text available with Trip Pro

Efficacy and safety of traditional Chinese medicine decoction combined with chemotherapy in the treatment of advanced colorectal cancer A protocol of a systematic review and meta-analysis Inplasy Protocol 700 - INPLASY.COM International Platform of Registered Systematic Review and Meta-analysis Protocols Main Menu Share this: Copyright © 2021 INPLASY.COM Powered by INPLASY.COM

2020 INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols

25. Self-expandable metal stents for obstructing colonic and extracolonic cancer: European Society of Gastrointestinal Endoscopy (ESGE) Guideline – Update 2020

389Introduction Colorectal cancer is one of the most common cancers world- wide, particularly in the economically developed world [1]. Large-bowel obstruction caused by advanced colonic cancer occurs in 8%–13% of colonic cancer patients [2–4]. The man- agementof thissevereclinicalconditionhasbeencontroversial [5].Over thelastdecade,manyarticleshavebeenpublishedon the subject of colonic stenting for malignant colonic obstruc- tion, including randomized controlled trials (RCTs) and sys- tematic reviews. Thereby (...) of metastasized colorectal cancer atdiagnosis[9].Colonoscopicnontraversability,i.e.,theinabil- itytoadvancethescopebeyondthetumor,hasbeensuggested as a risk factor for the development of symptomatic bowel ob- struction during treatment with primary chemotherapy [10– 12]. Nevertheless, prophylactic stenting for patients with colo- nicmalignancywithoutevidenceofsymptomaticobstructionis strongly discouraged because of the potential risks associated with colonic stenting. The only absolute contraindication

2020 European Society of Gastrointestinal Endoscopy

26. Localised Colon Cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

or tests using other markers (e.g. M2-PK) lack formal comparisons of their performance, and integration with other assays needs to be monitored. Screening for high-risk populations is covered in the ESMO guidelines for hereditary gastrointestinal cancer [11]. DIAGNOSIS Symptoms and signs Colon cancer arises from the mucosa of the bowel, growing both into the lumen and the bowel wall, and/or spreading to adjacent organs. Symptoms are associated with relatively large tumours and/or advanced disease (...) screened and in case of inherited syndromes, also referred for genetic counselling (see ESMO guidelines for hereditary gastrointestinal cancer [11]): ? a medical history of adenoma, colon cancer, inflammatory bowel disease (Crohn’s disease and ulcerative colitis); ? significant family history of CRC or adenoma; 4 ? an inherited cancer syndrome (2%–5% of all CRC), such as familial adenomatous polyposis coli and its variants (1%), Lynch-associated syndromes (hereditary non-polyposis colon cancer) (2%–4

2020 European Society for Medical Oncology

27. An RCT of Fecal Immunochemical Test Colorectal Cancer Screening in Veterans Without Recent Primary Care

An RCT of Fecal Immunochemical Test Colorectal Cancer Screening in Veterans Without Recent Primary Care An RCT of Fecal Immunochemical Test Colorectal Cancer Screening in Veterans Without Recent Primary Care - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. COVID-19 is an emerging, rapidly evolving situation. Get the latest public (...) new results Optional text in email: Save Cancel Create a file for external citation management software Create file Cancel Your RSS Feed Name of RSS Feed: Number of items displayed: Create RSS Cancel RSS Link Copy Actions Cite Share Permalink Copy Page navigation Am J Prev Med Actions . 2020 Jul;59(1):41-48. doi: 10.1016/j.amepre.2020.02.014. An RCT of Fecal Immunochemical Test Colorectal Cancer Screening in Veterans Without Recent Primary Care , , , , , Affiliations Expand Affiliations 1 Corporal

2020 EvidenceUpdates

28. Comparative Evaluation of Participation and Diagnostic Yield of Colonoscopy vs Fecal Immunochemical Test vs Risk-Adapted Screening in Colorectal Cancer Screening: Interim Analysis of a Multicenter Randomized Controlled Trial (TARGET-C)

Comparative Evaluation of Participation and Diagnostic Yield of Colonoscopy vs Fecal Immunochemical Test vs Risk-Adapted Screening in Colorectal Cancer Screening: Interim Analysis of a Multicenter Randomized Controlled Trial (TARGET-C) Comparative Evaluation of Participation and Diagnostic Yield of Colonoscopy vs Fecal Immunochemical Test vs Risk-Adapted Screening in Colorectal Cancer Screening: Interim Analysis of a Multicenter Randomized Controlled Trial (TARGET-C) - PubMed This site needs (...) Permalink Copy Page navigation Am J Gastroenterol Actions . 2020 Aug;115(8):1264-1274. doi: 10.14309/ajg.0000000000000624. Comparative Evaluation of Participation and Diagnostic Yield of Colonoscopy vs Fecal Immunochemical Test vs Risk-Adapted Screening in Colorectal Cancer Screening: Interim Analysis of a Multicenter Randomized Controlled Trial (TARGET-C) , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Affiliations Expand Affiliations 1 Office of Cancer Screening, National Cancer Center

2020 EvidenceUpdates

29. Tumor Control and Overall Survival after Stereotactic Body Radiotherapy for Pulmonary Oligometastases from Colorectal Cancer: a Meta-Analysis Full Text available with Trip Pro

/ 500 characters | | | | | > > Article Choi, Jeong, Kang, Jeong, Song, Ha, and Kwon: Tumor Control and Overall Survival after Stereotactic Body Radiotherapy for Pulmonary Oligometastases from Colorectal Cancer: A Meta-Analysis Original Article | Gastrointestinal cancer Cancer Res Treat. 2020; 52(4): 1188-1198. Published online: July 21, 2020 DOI: Tumor Control and Overall Survival after Stereotactic Body Radiotherapy for Pulmonary Oligometastases from Colorectal Cancer: A Meta-Analysis 1 , 2 , 1 , 2 (...) search terms were selected. The words and phrases chosen were lung, pulmonary, metastasis, recurrence, colorectal, colon, sigmoid, rectal, cancer, carcinoma, tumor, neoplasm, radiosurgery, stereotactic body radiotherapy, stereotactic radiotherapy, stereotactic ablative radiotherapy, stereotactic radiosurgery, SBRT, stereotactic radiotherapy, and stereotactic ablative radiotherapy. While performing for relevant studies, the publication date chosen was from database inception to September 3, 2019

2020 Cancer Research and Treatment

30. Efficacy and safety of sigmoidectomy for the treatment of sigmoid colon cancer: a protocol of systematic review Full Text available with Trip Pro

Efficacy and safety of sigmoidectomy for the treatment of sigmoid colon cancer: a protocol of systematic review INPLASY Protocol 520 - INPLASY.COM International Platform of Registered Systematic Review and Meta-analysis Protocols Main Menu Share this: Copyright © 2021 INPLASY.COM Powered by INPLASY.COM

2020 INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols

31. COX-2 gene rs689466 polymorphism is associated with increased risk of colorectal cancer among Caucasians: a meta-analysis Full Text available with Trip Pro

COX-2 gene rs689466 polymorphism is associated with increased risk of colorectal cancer among Caucasians: a meta-analysis COX-2 gene rs689466 polymorphism is associated with increased risk of colorectal cancer among Caucasians: a meta-analysis | Research Square Browse Tools & Services Your Cart See the published version of this article at . This is a preprint, a preliminary version of a manuscript that has not completed peer review at a journal. Research Square does not conduct peer review (...) prior to posting preprints. The posting of a preprint on this server should not be interpreted as an endorsement of its validity or suitability for dissemination as established information or for guiding clinical practice. Research COX-2 gene rs689466 polymorphism is associated with increased risk of colorectal cancer among Caucasians: a meta-analysis Yong-Chen Zhang, Hui Zhao, Chen Chen, Mohammad Amzad Ali Yong-Chen Zhang The second Hospital of Nanjing, Nanjing University of Chinese Medicine Hui

2020 Research Square

32. Correction to: Genome wide meta-analysis of cDNA datasets reveals new target gene signatures of colorectal cancer based on systems biology approach Full Text available with Trip Pro

Correction to: Genome wide meta-analysis of cDNA datasets reveals new target gene signatures of colorectal cancer based on systems biology approach Correction to: Genome wide meta-analysis of cDNA datasets reveals new target gene signatures of colorectal cancer based on systems biology approach | Journal of Biological Research-Thessaloniki | Full Text Search Search all BMC articles Search Correction to: Genome wide meta-analysis of cDNA datasets reveals new target gene signatures of colorectal (...) article [ ] has been corrected. Reference 1. Ilyas U, Zaman SU, Altaf R, et al. Genome wide meta-analysis of cDNA datasets reveals new target gene signatures of colorectal cancer based on systems biology approach. J of Biol Res-Thessaloniki. 2020;27:8. . Author information Affiliations Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, Riphah International University, Islamabad, 44000, Pakistan Umair Ilyas & Shahiq uz Zaman Department of Pharmaceutical Chemistry, Faculty

2020 Journal of Biological Research-Thessaloniki

33. Is 45 really the new 50 in colorectal cancer screening?

Is 45 really the new 50 in colorectal cancer screening? Tools for Practice is proudly sponsored by the Alberta College of Family Physicians (ACFP). ACFP is a provincial, professional voluntary organization, representing more than 4,800 family physicians, family medicine residents, and medical students in Alberta. Established over sixty years ago, the ACFP strives for excellence in family practice through advocacy, continuing medical education and primary care research. www.acfp.ca June 29, 2020 (...) Is 45 really the new 50 in colorectal cancer screening? Clinical Question: Should we lower the age that average risk patients commence colorectal cancer screening from 50 to 45? Bottom Line: In developed countries, the incidence of colorectal cancer in persons under 50 years old has increased by 20-30% in the last 20 years. However, the absolute risk increase is only 1-4 per 100,000 persons. Screening average risk patients under age 50 should not be encouraged at this time. Evidence: • Population

2020 Tools for Practice

34. Short-term Outcomes of Single-port Versus Multiport Laparoscopic Surgery for Colon Cancer: The SIMPLE Multicenter Randomized Clinical Trial

Short-term Outcomes of Single-port Versus Multiport Laparoscopic Surgery for Colon Cancer: The SIMPLE Multicenter Randomized Clinical Trial Short-term Outcomes of Single-port Versus Multiport Laparoscopic Surgery for Colon Cancer: The SIMPLE Multicenter Randomized Clinical Trial - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable (...) Your RSS Feed Name of RSS Feed: Number of items displayed: Create RSS Cancel RSS Link Copy Actions Cite Share Permalink Copy Page navigation Ann Surg Actions . 2020 Mar 20. doi: 10.1097/SLA.0000000000003882. Online ahead of print. Short-term Outcomes of Single-port Versus Multiport Laparoscopic Surgery for Colon Cancer: The SIMPLE Multicenter Randomized Clinical Trial , , , , , , , , Affiliations Expand Affiliations 1 Department of Surgery, Seoul St. Mary Hospital, College of Medicine, The Catholic

2020 EvidenceUpdates

35. A systematic mixed studies review of health behaviour change interventions in colorectal cancer survivors

A systematic mixed studies review of health behaviour change interventions in colorectal cancer survivors A systematic mixed studies review of health behaviour change interventions in colorectal cancer survivors - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. National Institutes of Health National Library of Medicine National (...) RSS Cancel RSS Link Copy Actions Cite Share Permalink Copy Page navigation Review J Adv Nurs Actions . 2020 Apr 13. doi: 10.1111/jan.14389. Online ahead of print. A systematic mixed studies review of health behaviour change interventions in colorectal cancer survivors , , , Affiliations Expand Affiliation 1 School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada. PMID: 32281687 DOI: Item in Clipboard Review A systematic mixed studies review

2020 EvidenceUpdates

36. Exposure to Particulate Matter Air Pollution and the Incidence and Mortality of GI Cancers: A Systematic Review Full Text available with Trip Pro

Exposure to Particulate Matter Air Pollution and the Incidence and Mortality of GI Cancers: A Systematic Review Exposure to Particulate Matter Air Pollution and the Incidence and Mortality of GI Cancers: A Systematic Review | JCO Global Oncology Search in: Menu > > > > Article Tools MEETING PROCEEDINGS Article Tools OPTIONS & TOOLS COMPANION ARTICLES No companion articles ARTICLE CITATION DOI: 10.1200/GO.20.15000 JCO Global Oncology 6 no. Supplement_1 (2020) 20-20. Published online July 27 (...) , 2020. Exposure to Particulate Matter Air Pollution and the Incidence and Mortality of GI Cancers: A Systematic Review , BS, BA 1 x Emily Spangler ; , PhD, MS 2 x Rena Jones ; , MA, MPH 3 x Alicia Livinski ; , MD 2 x Sanford Dawsey ; and , MPH 2 x Natalie Haley 1 Roanoke College, Salem, VA 2 National Cancer Institute, Rockville, MD 3 National Institutes of Health, Bethesda, MD Licensed under the Creative Commons Attribution 4.0 License: Abstract PURPOSE High levels of particulate matter (PM) air

2020 JCO global oncology

37. Clinicopathological and prognostic significance of Fusobacterium nucleatum infection in colorectal cancer: a meta-analysis Full Text available with Trip Pro

Clinicopathological and prognostic significance of Fusobacterium nucleatum infection in colorectal cancer: a meta-analysis Clinicopathological and prognostic significance of Fusobacterium nucleatum infection in colorectal cancer: a meta-analysis | Research Square Browse Tools & Services Your Cart This is a preprint, a preliminary version of a manuscript that has not completed peer review at a journal. Research Square does not conduct peer review prior to posting preprints. The posting (...) of a preprint on this server should not be interpreted as an endorsement of its validity or suitability for dissemination as established information or for guiding clinical practice. Research article Clinicopathological and prognostic significance of Fusobacterium nucleatum infection in colorectal cancer: a meta-analysis Shuchen Huangfu, Wen-bin Zhang, haoran Zhang, Yang Li, Yiran Zhang, Xiaodong Chu, Jinling Nie, Changshun Chen, Hai-ping Jiang, Jing-hua Pan Shuchen Huangfu Jinan University First Affiliated

2020 Research Square

38. Relationship between aspirin use of esophageal, gastric and colorectal cancer patient survival: a meta-analysis Full Text available with Trip Pro

survival in patients with gastrointestinal cancer. The aim of this study was to assess the survival benefit of aspirin use compared with non-aspirin use for patients with esophageal, gastric or colorectal cancer. Methods : We searched online databases, including PubMed, the Cochrane Library, Embase and for studies that were conducted, before April 30th, 2020, to identify relevant studies. Overall survival and cancer-specific survival of esophageal, gastric and colorectal cancers among aspirin users (...) Relationship between aspirin use of esophageal, gastric and colorectal cancer patient survival: a meta-analysis Relationship between aspirin use of esophageal, gastric and colorectal cancer patient survival: a meta-analysis | Research Square Browse Tools & Services Your Cart See the published version of this article at . This is a preprint, a preliminary version of a manuscript that has not completed peer review at a journal. Research Square does not conduct peer review prior to posting

2020 Research Square

39. Relationship between aspirin use of esophageal, gastric and colorectal cancer patient survival: a meta-analysis Full Text available with Trip Pro

found that use of aspirin can lengthen survival in patients with gastrointestinal cancer. The aim of this study was to assess the survival benefit of aspirin use compared with non-aspirin use for patients with esophageal, gastric or colorectal cancer. Methods : We searched online databases, including PubMed, the Cochrane Library, Embase and www.clinicaltrials.gov for studies that were conducted,, before April 30th, 2020, to identify relevant studies. Overall survival and cancer-specific survival (...) Relationship between aspirin use of esophageal, gastric and colorectal cancer patient survival: a meta-analysis Relationship between aspirin use of esophageal, gastric and colorectal cancer patient survival: a meta-analysis | Research Square Browse Tools & Services Your Cart See the published version of this article at . This is a preprint, a preliminary version of a manuscript that has not completed peer review at a journal. Research Square does not conduct peer review prior to posting

2020 Research Square

40. Does frailty predict postoperative outcomes in geriatric patients receiving surgery for colorectal cancer? A systematic review and meta-analysis Full Text available with Trip Pro

Does frailty predict postoperative outcomes in geriatric patients receiving surgery for colorectal cancer? A systematic review and meta-analysis Does frailty predict postoperative outcomes in geriatric patients receiving surgery for colorectal cancer? A systematic review and meta-analysis | Research Square Browse Tools & Services Your Cart This preprint is under consideration at BMC Geriatrics . A preprint is a preliminary version of a manuscript that has not completed peer review at a journal (...) . Research Square does not conduct peer review prior to posting preprints. The posting of a preprint on this server should not be interpreted as an endorsement of its validity or suitability for dissemination as established information or for guiding clinical practice. Research article Does frailty predict postoperative outcomes in geriatric patients receiving surgery for colorectal cancer? A systematic review and meta-analysis XIAOBO YANG, Chenying Xu, Jiumei Cao, Li Xie, Qingqing Qiu, Jiaan Hu, Lifen

2020 Research Square